Open access
Aug 2026
Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy
<strong>A prime resistance mechanism of glioblastoma to temozolomide is a vulnerability to radiation therapy</strong>
Vlad Moisoiu, Roxanne Lourman, Frank Szulzewsky et al.
· Journal of Clinical Investig... · 0 citations